Journal
JOURNAL OF IMMUNOLOGY
Volume 182, Issue 3, Pages 1696-1705Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.182.3.1696
Keywords
-
Categories
Funding
- Conseil Regional d'Ile de France
- Ministre de la Recherche
Ask authors/readers for more resources
To characterize the immune defect of patients with end-stage renal disease (ESRD), we performed NK cell subset analysis in 66 patients with ESRD treated by hemodialysis (n = 59) or peritoneal dialysis (n = 7). Compared with healthy blood donors, patients undergoing chronic dialysis showed a profound decrease in NKG2D(+) cells within both the CD8(+) T cell (58% vs 67%, p = 0.03) and NK cell (39% vs 56%, p = 0.002) populations. CD56(dim) cells, which comprise the majority of NK cells in the periphery, were more affected in this regard than were CD56(bright) cells. Uremic serum could decrease NKG2D expression on NK cells from healthy donors. Among factors that could contribute to the decrease in NKG2D expression in ESRD patients, reactive oxygen species (ROS) play a major role. We found that catalase could reverse the effects of uremic serum on NKG2D expression (p < 0.001) and that ROS down-regulated NKG2D at the mRNA level and at the NK cell surface. Additionally, ESRD patients had both increased membrane-bound MHC class I-related chain A (MICA) on monocytes; (p = 0.04) and increased soluble MICA (203 pg/ml vs 110 pg/ml;p < 0.001). Both ROS and uremic serum could significantly increase in vitro the expression or the NKG2D ligand MICA on the renal epithelial cell line HK-2. Taken together, these studies suggest for the first time that both low NKG2D expression and up-regulation of its ligand MICA are related to ROS production and may be involved in the immune deficiency of ESRD patients. The Journal of Immunology, 2009, 182: 1696-1705.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available